Work

The Taylor Family Institute at Washington University: Novel Treatments in Psychiatry.

Year: 2023

Type: article

Abstract: Efforts to develop more effective treatments for psychiatric illnesses will require innovative approaches that address changes in brain networks underlying cognition, emotion and motivation, cardinal symptoms that cut across all psychiatric disorders. This effort will include new molecular entities that modulate neuronal excitability, synapses, cellular stress and inflammation. Other opportunities will come from repurposing existing treatments. This overview highlights current and future goals in treatment development in the Taylor Family Institute for Innovative Psychiatric Research at Washington University.

Source: PubMed Central

Authors: Charles F Zorumski, Steven J Mennerick

Institutions: Washington University in St. Louis, Taylor Family Institute for Innovative Psychiatric Research

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Mental Health

Awards: Oxysterols and NMDAR Function, GABAA RECEPTOR POPULATIONS IN HIPPOCAMPUS AND THALAMUS, Neuroactive steroids as novel psychiatric treatments: mechanistic studies